Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01249352
What this trial is testing

Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal CancerAdenocarcinoma
Eurofarma Laboratorios S.A. 104
Not applicableUnknownNCT04466631
What this trial is testing

Health and Employment After Gastro Intestinal Surgery - HEAGIS2

Who this might be right for
Esophageal NeoplasmsGastric NeoplasmColon Neoplasms
University of Padova 50
Not applicableUnknownNCT05053295
What this trial is testing

Investigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With Nivolumab (Opdivo) in Subjects With Advanced or Recurrent Gastric Cancer

Who this might be right for
Relapsed or Advanced Gastric AdenocarcinomaGastro-esophageal Junction Cancer
Gangnam Severance Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06199895
What this trial is testing

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

Who this might be right for
Pancreatic AdenocarcinomaCholangiocarcinomaLung Cancer+3 more
Liu Huang 25
Testing effectiveness (Phase 2)UnknownNCT00057395
What this trial is testing

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Who this might be right for
Esophageal NeoplasmsHepatocellular CarcinomaColorectal Neoplasms+3 more
Aronex Pharmaceuticals 40
Not applicableAvailableNCT04566393
What this trial is testing

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Who this might be right for
Pancreatic CancerSmall Bowel CancerColorectal Cancer+18 more
xCures
Not applicableUnknownNCT03908671
What this trial is testing

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer

Who this might be right for
Esophageal CancerNon Small Cell Lung Cancer
Stemirna Therapeutics 24
Not applicableUnknownNCT02149914
What this trial is testing

The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients

Who this might be right for
Non-erosive Reflux DiseaseBarrett's Esophagus
Taichung Tzu Chi Hospital 120
Testing effectiveness (Phase 2)UnknownNCT04819971
What this trial is testing

Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC

Who this might be right for
Stomach Cancer
The First Affiliated Hospital of Zhengzhou University 67
Not applicableStudy completedNCT03434834
What this trial is testing

OCT Pilot in Esophagus

Who this might be right for
Barrett Esophagus
Duke University 53
Not applicableEnrolling By InvitationNCT00587314
What this trial is testing

The Effect of Ablation Therapy on Barrett's Esophagus

Who this might be right for
Barrett's EsophagusEarly Esophageal Adenocarcinoma
Mayo Clinic 600
Not applicableNot Yet RecruitingNCT07353541
What this trial is testing

Standardized Management of Esophageal Fistula in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Esophageal Fistula
Peking University Cancer Hospital & Institute 32
Testing effectiveness (Phase 2)Study completedNCT00590031
What this trial is testing

Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.

Who this might be right for
Esophageal Carcinoma
Memorial Sloan Kettering Cancer Center 61
Not applicableUnknownNCT05543057
What this trial is testing

Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision Radiotherapy

Who this might be right for
Esophageal Cancer
Zefen Xiao 150
Not applicableStudy completedNCT02415101
What this trial is testing

Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Cancer of the Esophagus
Karolinska University Hospital 202
Testing effectiveness (Phase 2)Study completedNCT00730353
What this trial is testing

Sutent + Taxol for Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Hoosier Cancer Research Network 28
Testing effectiveness (Phase 2)Looking for participantsNCT06675201
What this trial is testing

Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Neoantigen-loaded Dendritic Cell VaccineImmune Checkpoint Inhibitors (ICIs)
Sichuan University 165
Not applicableLooking for participantsNCT05443841
What this trial is testing

Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)

Who this might be right for
Esophageal Cancer
Fudan University 385
Not applicableUnknownNCT05028231
What this trial is testing

Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapies
Tongji Hospital 46
Testing effectiveness (Phase 2)UnknownNCT05990231
What this trial is testing

Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 35
Next Page